HPV- and node status in cervical cancer. Long-term results

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 71, Issue 2, 1997, Pages 169-172

  Póka, Robert ^a   Czeglédy, Judit ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

cervical cancer; human papillomavirus; lymph node; survival

Indexed keywords

CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PELVIS LYMPH NODE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; WART VIRUS;

EID: 0031080802     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(96)02629-2     Document Type: Conference Paper

References (15)

1. [1] Kenter GG, Cornelisse C, Jiwa NM, Aartsen EJ, Hermans J, Mooi W, Heintz AP, Fleuren GJ. Human papillomavirus type 16 in tumor tissue of low-stage squamous carcinoma of the uterine cervix in relation to ploidy grade and prognosis. Cancer 1993; 71(2): 397-401.
2. [2] Thomassen LV, Warshaw J, Lawhead RAJr, Unger ER. Invasive cervical cancer in young women. clinicopathotogic correlation and demonstration of human papillomavirus by in situ hybridization. J Reprod Med 1992; 37(11): 901-906.
3. [3] Tosi P, Cintorino M, Santopietro R, Lio R, Barbini P, Ji H, Chang F, Kataja V, Syrjanen S, Syrjanen K. Prognostic factors in invasive cervical carcinomas associated with human papillomavirus (HPV). Quantitative data and cytokeratin expression. Pathol Res Pract 1993; 188(7): 866-873.
4. [4] Franco EL. Prognostic value of human papillomavirus in the survival of cervical cancer patients: an overview of the evidence. Cancer Epidemiol Biomarkers Prev 1992; 1(6): 499-504.
5. [5] Higgins GD, Davy M. Roder D, Uzelin DM, Phillips GE, Burrell CJ. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 1991; 338(8772): 910-913.
6. [6] Sebbelov AM, Kjorstad KE, Abeler VM, Norrild B. The prevalence of human papillomavirus type 16 and 18 DNA in cervical cancer in different age groups: a study on the incidental cases of cervical cancer in Norway in 1983. Gynecol Oncol 1991; 41(2): 141-148.
7. [7] Póka R, Czeglédy J, Hernádi Z. Humán papillomavírusok kimutatása méhnyakrákban. Magy Nôorv L 1991; 54: 48-50.
8. [8] Póka R. Czeglédy J, Hernádi Z, Gergely L, Lampé L. Stage-related detection rate of human papillomavirus DNA in invasive cervical cancer. J Obstet Gynecol 1991; 11: 448-450.
9. [9] Póka R, Czeglédy J, Gergely L, Lampé L. Potential contribution of human papillomavirus testing to cervical cancer screening. CHn Exp Obstet Gynecol 1994; 21(3): 203-206.
10. [10] Czeglédy J, Gergely L, Hernádi Z, Póka R. Papillomavirus DNS kimutatása a nôi genitális rendszer alsó szakaszában. Orv Hetil 1988; 129(31): 1637-1640.
11. [11] Papp Z, Lampé L. A kiterjesztett hasi méheltávolítás és lymphadenectomia (Wertheim-mûtét) helye a mai nôgyógyászatban. Orv Hetil 1989; 130: 1481-1485.
12. [12] Póka R, Szluha K, Hernádi Z, Juhász B, Lampé L. Analysis of survival in stage Ib and IIa cervical cancer treated with or without preoperative local radiotherapy. Eur J Gynecol Oncol 1995; 16(3): 208-211.
13. [13] Czeglédy J, Gergely L, Hernádi Z, Póka R. Detection of human papillomavirus deoxyribonucleic acid in the female genital tract. Med Microbiol Immunol 1989; 178: 309-314.
14. [14] Czeglédy J, Póka R, Veress G, Gergely L. Amplification of human papillomavirus type 16 transforming genes from cervical cancer biopsies and lymph nodes of Hungarian patients. J Clin Microbiol 1992; 30(1): 233-236.
15. [15] Póka R, Juhász B, Lampé L. Cervical cancer in young women: a poorer prognosis? Int J Gynecol Obstet 1994; 46:33-37.